
  
    
      
        Background_NNP
        Rapid_NNP and_CC accurate_JJ methods_NNS are_VBP needed_VBN for_IN the_DT diagnosis_NN
        of_IN 
        Plasmodium_NNP falciparum_NN malaria_NN [_NN 1_CD 2_CD ]_NN
        as_IN malaria_NN is_VBZ estimated_VBN to_TO kill_VB between_IN 1_CD ._. 4_CD and_CC 2_CD ._. 6_CD million_CD
        people_NNS each_DT year_NN [_NN 1_CD ]_NN ._. WHO_WP South_NNP East_NNP Asian_JJ regional_JJ
        office_NN estimates_VBZ 19500_CD deaths_NNS due_JJ to_TO malaria_NN in_IN India_NNP
        annually_RB [_NN 3_CD ]_NN ._. 
        P_NN ._. falciparum_NN infections_NNS in_IN children_NNS
        may_MD become_VB life_NN threatening_VBG making_VBG rapid_JJ diagnosis_NN of_IN
        extreme_JJ importance_NN [_NN 4_CD ]_NN ._. No_DT clinical_JJ diagnostic_JJ criteria_NNS
        are_VBP both_DT sensitive_JJ and_CC specific_JJ for_IN malaria_NN ,_, an_DT
        undifferentiated_JJ febrile_NN illness_NN [_NN 5_CD ]_NN which_WDT may_MD result_VB in_IN
        the_DT erroneous_JJ treatment_NN of_IN millions_NNS of_IN non-malaria_JJ cases_NNS
        with_IN antimalarial_NN drugs_NNS in_IN the_DT absence_NN of_IN diagnostic_JJ
        malaria_NN microscopy_NN ._. Excessive_NNP antimalarial_NN drug_NN use_NN is_VBZ
        costly_JJ ,_, propels_NNS the_DT emergence_NN of_IN drug_NN resistant_JJ parasites_NNS ,_,
        speeds_VBZ the_DT obsolescence_NN of_IN affordable_JJ drugs_NNS and_CC retards_NNS
        malaria_NN control_NN [_NN 6_CD ]_NN ._. Prompt_NNP diagnosis_NN and_CC effective_JJ
        treatment_NN of_IN malaria_NN improves_VBZ prognosis_NN [_NN 2_CD ]_NN ._. In_IN the_DT
        absence_NN of_IN diagnostic_JJ microscopy_NN in_IN resource_NN poor_JJ ,_, remote_JJ
        villages_NNS of_IN tribal_NN forested_JJ belt_NN of_IN central_JJ India_NNP ,_, the_DT
        detection_NN of_IN 
        P_NN ._. falciparum_NN histidine_NN rich_JJ protein_NN
        2_CD (_( Pf_NNP HRP-_NNP 2_LS )_) in_IN a_DT blood_NN specimen_NN is_VBZ one_CD method_NN by_IN which_WDT
        expeditious_JJ diagnosis_NN of_IN 
        falciparum_NN malaria_NN can_MD be_VB made_VBN on_IN the_DT
        spot_NN [_NN 7_CD 8_CD ]_NN ._. Recently_RB introduced_VBN rapid_JJ malaria_NN test_NN ,_,
        Determine_NNP ™_NN malaria_NN pf_NN (_( Abbott_NNP Laboratories_NNPS ,_, Japan_NNP )_) have_VBP
        been_VBN evaluated_VBN for_IN its_PRP$ effectiveness_NN in_IN detecting_VBG 
        P_NN ._. falciparum_NN malaria_NN in_IN Philippines_NNPS
        [_NN 9_CD ]_NN and_CC in_IN central_JJ India_NNP [_NN 10_CD ]_NN ._.
        This_DT field_NN study_NN appraised_VBN the_DT performance_NN of_IN the_DT rapid_JJ
        diagnostic_JJ test_NN in_IN assessing_VBG the_DT impact_NN of_IN antimalarial_NN
        intervention_NN measures_NNS in_IN villages_NNS of_IN two_CD adjacent_JJ Primary_JJ
        Health_NNP Centre_NNP 's_POS of_IN district_NN Mandla_NNP ,_, central_JJ India_NNP ._. For_IN this_DT
        study_NN we_PRP performed_VBD a_DT blinded_JJ microscopy_NN and_CC splenomegly_RB in_IN
        children_NNS as_IN the_DT endemicity_NN of_IN malaria_NN is_VBZ usually_RB
        characterized_VBN by_IN spleen_NN and_CC parasites_NNS rates_NNS in_IN children_NNS [_NN
        11_CD ]_NN ._.
      
      
        Material_NNP and_CC methods_NNS
        
          Study_NN area_NN and_CC study_NN population_NN
          This_DT Study_NNP was_VBD undertaken_VBN in_IN two_CD Primary_JJ Health_NNP
          Centre_NNP 's_POS (_( PHC_NNP )_) of_IN district_NN Mandla_NNP ._. The_DT entire_JJ region_NN is_VBZ
          undulating_VBG and_CC hilly_JJ ._. The_DT villages_NNS are_VBP generally_RB located_VBN
          on_IN the_DT slopes_NNS of_IN the_DT hillocks_NNS or_CC on_IN hill_NN tops_NNS adjoining_JJ
          perennial_JJ streams_NNS ._. The_DT inhabitants_NNS are_VBP (_( gond_NN ethnic_JJ
          tribe_NN )_) illiterate_JJ ,_, poorly_RB clothed_VBN ,_, health_NN ignorant_NN and_CC
          work_NN in_IN forest_NN or_CC road_NN construction_NN work_NN etc_FW ._. An_DT outbreak_NN
          of_IN 
          P_NN ._. falciparum_NN was_VBD recorded_VBN in_IN
          villages_NNS of_IN Bizadandi_NNP PHC_NNP in_IN 1995_CD (_( unpublished_JJ
          observation_NN )_) ,_, while_IN in_IN villages_NNS of_IN Narayanganj_NNP PHC_NNP in_IN
          1996_CD [_NN 12_CD ]_NN ._. Appropriate_NNP intervention_NN measures_NNS were_VBD
          undertaken_VBN in_IN both_DT the_DT areas_NNS by_IN National_NNP Anti_NNP Malaria_NNP
          Programme_NNP (_( N_NNP ._. A_DT ._. M_NNP ._. P_NN )_) which_WDT are_VBP described_VBN previously_RB [_NN 13_CD ]_NN
          ._. Briefly_NNP two_CD rounds_NNS of_IN focal_JJ spraying_VBG with_IN DDT_NNP (_( 1_CD g_SYM /_NN m_NN 2_LS )_)
          along_IN with_IN prompt_VB surveillance_NN and_CC treatment_NN to_TO bring_VB the_DT
          incidence_NN of_IN malaria_NN under_IN control_NN ._.
          For_IN monitoring_VBG the_DT impact_NN of_IN intervention_NN measures_NNS in_IN
          these_DT two_CD PHC_NNP 's_POS ,_, children_NNS aged_VBN 2_CD -_: 10_CD yrs_NNS with_IN and_CC without_IN
          fever_NN were_VBD examined_VBN for_IN spleen_NN enlargement_NN [_NN 14_CD ]_NN in_IN
          three_CD villages_NNS of_IN each_DT PHC_NNP during_IN autumn_NN season_NN
          (_( December_NNP ,_, 1999_CD )_) ,_, by_IN one_CD medical_JJ specialist_NN by_IN
          establishing_VBG a_DT mobile_JJ field_NN clinic_NN after_IN obtaining_VBG
          informed_VBN consent_NN from_IN their_PRP$ parents_NNS ._. Treatment_NNP was_VBD given_VBN
          when_WRB appropriate_JJ as_IN per_IN Indian_NNP N_NNP ._. A_DT ._. M_NNP ._. P_NN ._. The_DT study_NN is_VBZ
          approved_VBN by_IN ethic_JJ committee_NN of_IN Malaria_NNP Research_NNP Centre_NNP
          (_( I_NN ._. C_NNP ._. M_NNP ._. R_NN )_) ,_, Delhi_NNP ._.
        
        
          Sampling_NNP and_CC data_NNS analysis_NN
          From_IN these_DT children_NNS thick_JJ blood_NN smears_NNS were_VBD prepared_VBN
          from_IN finger_NN prick_NN and_CC read_VBN by_IN a_DT technician_NN unaware_JJ of_IN the_DT
          spleen_NN results_NNS ._. Parasites_NNP were_VBD counted_VBN against_IN 200_CD white_JJ
          blood_NN cells_NNS and_CC converted_VBN into_IN counts_VBZ /_NN μl_NN assuming_VBG the_DT
          average_JJ count_NN is_VBZ 8000_CD μl_NN ._. Simultaneously_RB ,_, rapid_JJ tests_NNS
          were_VBD performed_VBN by_IN a_DT field_NN lab_NN attendant_NN after_IN only_RB a_DT
          brief_NN on_IN the_DT spot_NN training_NN according_VBG to_TO the_DT
          manufacturer_NN 's_POS instructions_NNS taking_VBG about_IN 30_CD minutes_NNS to_TO
          provide_VB one_CD result_NN without_IN reference_NN to_TO the_DT results_NNS of_IN
          the_DT thick_JJ smear_NN and_CC spleen_NN ._. The_DT thick_JJ smears_NNS were_VBD
          re-examined_JJ to_TO discard_VB a_DT false_JJ negative_JJ results_NNS ,_, combined_VBN
          infections_NNS or_CC misdiagnosis_NNS of_IN species_NNS by_IN an_DT experienced_VBN
          technician_NN who_WP was_VBD blinded_JJ to_TO the_DT previous_JJ results_NNS of_IN
          thick_JJ smears_NNS ._. The_DT figures_NNS for_IN specificity_NN ,_, sensitivity_NN
          and_CC predictive_JJ values_NNS were_VBD calculated_VBN as_IN described_VBN
          previously_RB [_NN 10_CD ]_NN using_VBG microscopy_NN as_IN gold_NN standard_JJ ._.
          Briefly_NNP ,_, sensitivity_NN was_VBD calculated_VBN as_IN TP_NNP /_NN (_( TP_NNP +_NN FN_NNP )_) ,_,
          specificity_NN as_IN TN_NNP /_NN (_( TN_NNP +_NN FP_NNP )_) ,_, the_DT positive_JJ predictive_JJ
          values_NNS (_( PPV_NNP )_) as_IN TP_NNP /_NN (_( TP_NNP +_NN FP_NNP )_) ,_, and_CC the_DT negative_JJ
          predictive_JJ values_NNS (_( NPV_NNP )_) as_IN TN_NNP /_NN (_( FN_NNP +_NN TN_NNP )_) ._. The_DT test_NN
          accuracy_NN ,_, the_DT proportion_NN of_IN all_DT tests_NNS that_WDT gave_VBD correct_JJ
          result_NN ,_, was_VBD defined_VBN as_IN (_( TP_NNP +_NN TN_NNP )_) /_NN numbers_NNS of_IN all_DT tests_NNS ._.
          The_DT mixed_JJ infection_NN of_IN 
          P_NN ._. vivax_NN and_CC 
          P_NN ._. falciparum_NN are_VBP treated_VBN as_IN
          falciparum_NN cases_NNS for_IN the_DT purpose_NN of_IN analysis_NN ._. Likewise_RB ,_,
          the_DT instances_NNS of_IN gametocytes_NNS only_RB are_VBP classified_VBN as_IN false_JJ
          positives_NNS since_IN gametocytes_NNS neither_DT cause_NN illness_NN nor_CC
          require_VB treatment_NN with_IN blood_NN stage_NN schizonticidal_NN drugs_NNS ._.
          The_DT Z-_NNP test_NN was_VBD used_VBN for_IN comparison_NN between_IN
          proportions_NNS ._.
        
      
      
        Results_NNS
        Spleen_NNP examination_NN of_IN 199_CD and_CC 150_CD children_NNS respectively_RB
        in_IN Narayanganj_NNP and_CC Bizadandi_NNP Primary_JJ Health_NNP Centres_NNP (_( PHC_NNP )_)
        are_VBP shown_VBN in_IN Table_NNP 1_CD ._. The_DT spleen_NN rate_NN among_IN children_NNS who_WP
        lived_VBD in_IN the_DT villages_NNS of_IN Narayanganj_NNP PHC_NNP (_( 78_CD %_NN )_) was_VBD
        significantly_RB higher_JJR (_( P_NN <_NN 0_CD ._. 0001_CD )_) than_IN that_DT among_IN
        children_NNS of_IN Bizadandi_NNP (_( 24_CD %_NN )_) ._. Fever_NN was_VBD found_VBN in_IN 16_CD ._. 1_LS and_CC
        3_CD ._. 3_CD %_NN children_NNS in_IN Narayanganj_NNP and_CC Bizadandi_NNP PHC_NNP 's_POS
        respectively_RB without_IN spleen_NN enlargement_NN ._. The_DT sensitivity_NN
        and_CC specificity_NN of_IN spleen_NN in_IN detecting_VBG malaria_NN infections_NNS
        were_VBD 57_CD and_CC 74_CD %_NN respectively_RB (_( Table_NNP 2_LS )_) ._. The_DT positive_JJ
        predictive_JJ value_NN (_( PPV_NNP )_) 73_CD %_NN ,_, negative_JJ predictive_JJ value_NN (_( NPV_NNP )_)
        59_CD %_NN and_CC accuracy_NN were_VBD 65_CD %_NN ._. On_IN the_DT contrary_NN ,_, fever_NN without_IN
        spleen_NN had_VBD relatively_RB high_JJ sensitivity_NN of_IN 84_CD %_NN (_( P_NN <_NN
        0_CD ._. 001_CD )_) in_IN detecting_VBG malaria_NN infections_NNS though_IN specificity_NN
        is_VBZ significantly_RB lower_JJR (_( 62_CD %_NN )_) ._. The_DT PPV_NNP ,_, NPV_NNP and_CC accuracy_NN
        were_VBD 79_CD ,_, 96_CD and_CC 64_CD %_NN respectively_RB ._.
        The_DT performance_NN of_IN rapid_JJ test_NN vs_NNS thick_JJ smears_NNS are_VBP shown_VBN
        in_IN Table_NNP 3_CD ._. A_DT good_JJ agreement_NN was_VBD found_VBN indicating_VBG high_JJ
        sensitivity_NN of_IN 91_CD %_NN which_WDT is_VBZ significantly_RB higher_JJR than_IN that_DT
        of_IN spleen_NN (_( P_NN <_NN 0_CD ._. 0001_CD )_) ._. However_RB ,_, specificity_NN was_VBD 79_CD ._. 6_CD %_NN ,_,
        which_WDT is_VBZ not_RB significant_JJ when_WRB compared_VBN with_IN specificity_NN of_IN
        spleen_NN (_( Table_NNP 4_LS )_) ._. The_DT PPV_NNP 79_CD %_NN (_( P_NN <_NN 0_CD ._. 05_CD )_) ,_, NPV_NNP 91_CD %_NN (_( P_NN
        <_NN 0_CD ._. 0001_CD )_) and_CC accuracy_NN 85_CD %_NN (_( P_NN <_NN 0_CD ._. 0001_CD )_) were_VBD all_DT
        significantly_RB higher_JJR when_WRB compared_VBN with_IN their_PRP$ respective_JJ
        values_NNS of_IN spleen_NN ._. In_IN all_DT 11_CD cases_NNS showed_VBD positive_JJ reaction_NN
        by_IN rapid_JJ test_NN for_IN 
        P_NN ._. falciparum_NN while_IN blood_NN smears_NNS were_VBD
        negative_JJ for_IN malaria_NN parasite_NN ._. A_DT prolonged_JJ re-examination_NN
        of_IN these_DT slides_NNS who_WP were_VBD positive_JJ by_IN the_DT rapid_JJ test_NN ,_, but_CC
        apparently_RB had_VBD negative_JJ slides_NNS ,_, did_VBD not_RB reveal_VB the_DT presence_NN
        of_IN 
        P_NN ._. falciparum_NN asexual_NN parasites_NNS ._.
        Further_RB of_IN the_DT eight_CD subjects_NNS with_IN 
        P_NN ._. falciparum_NN infection_NN not_RB detected_VBN
        by_IN rapid_JJ test_NN ,_, not_RB all_DT had_VBD low_JJ parasitaemia_NN :_: five_CD had_VBD
        parasite_NN densities_NNS between_IN 60_CD -_: 318_CD /_NN μl_NN ,_, but_CC the_DT three_CD others_NNS
        had_VBD densities_NNS between_IN 600_CD -_: 1000_CD /_NN μl_NN ._. Out_IN of_IN 14_CD gametocytes_NNS of_IN
        
        P_NN ._. falciparum_NN ,_, only_RB 8_CD (_( 57_CD %_NN )_) were_VBD
        positive_JJ by_IN rapid_JJ test_NN ._.
        In_IN addition_NN ,_, 2_CD subjects_NNS with_IN 
        P_NN ._. vivax_NN as_IN detected_VBN by_IN microscopy_NN
        (_( 2795_CD ._. 81_CD ±_NN 3_CD ._. 58_CD /_NN (_( μl_NN )_) were_VBD found_VBN positive_JJ for_IN 
        P_NN ._. falciparum_NN by_IN rapid_JJ test_NN ._.
      
      
        Discussion_NNP
        Malaria_NNP diagnosis_NN ,_, is_VBZ often_RB made_VBN on_IN the_DT basis_NN of_IN
        presumptive_JJ symptoms_NNS although_IN this_DT is_VBZ alarmingly_RB inaccurate_JJ
        [_NN 15_CD 16_CD 1_CD ]_NN ._. One_CD of_IN the_DT earliest_JJS methods_NNS used_VBN for_IN
        estimation_NN of_IN the_DT amount_NN of_IN malaria_NN in_IN a_DT given_VBN locality_NN is_VBZ
        that_IN of_IN determining_VBG the_DT proportion_NN of_IN person_NN with_IN a_DT
        palpable_JJ enlargement_NN of_IN the_DT spleen_NN ._. This_DT method_NN introduced_VBN
        by_IN Dempster_NNP in_IN India_NNP in_IN 1848_CD is_VBZ commonly_RB used_VBN although_IN it_PRP
        is_VBZ admittedly_RB a_DT rough_JJ index_NN for_IN malaria_NN diagnosis_NN and_CC
        assessment_NN [_NN 17_CD ]_NN ._. However_RB ,_, it_PRP is_VBZ still_RB considered_VBN a_DT
        diagnostic_JJ aid_NN to_TO every_DT physician_NN as_IN the_DT spleen_NN rate_NN is_VBZ
        easier_JJR to_TO obtain_VB than_IN the_DT parasite_NN rate_NN [_NN 18_CD ]_NN ._.
        In_IN this_DT study_NN large_JJ number_NN of_IN cases_NNS with_IN enlarged_JJ spleen_NN
        in_IN Narayanganj_NNP PHC_NNP were_VBD asymptomatic_JJ ,_, of_IN which_WDT fairly_RB large_JJ
        number_NN were_VBD having_VBG malaria_NN parasites_NNS ._. Thus_RB ,_, in_IN this_DT
        population_NN a_DT positive_JJ correlation_NN between_IN malaria_NN and_CC
        splenomegaly_RB was_VBD observed_VBN as_IN recorded_VBN elsewhere_RB [_NN 18_CD 19_CD ]_NN ._.
        However_RB ,_, it_PRP requires_VBZ the_DT services_NNS of_IN a_DT medical_JJ specialist_NN
        who_WP is_VBZ not_RB certain_JJ whether_IN the_DT spleen_NN is_VBZ entirely_RB due_JJ to_TO
        malaria_NN ._. On_IN the_DT contrary_JJ ,_, rapid_JJ test_NN indicate_VBP the_DT presence_NN
        of_IN 
        P_NN ._. falciparum_NN easily_RB and_CC accurately_RB
        and_CC since_IN it_PRP requires_VBZ no_DT laboratory_NN or_CC technical_JJ equipment_NN ,_,
        a_DT diagnostic_JJ facility_NN can_MD be_VB set_VBN up_RP in_IN the_DT most_RBS remote_JJ
        areas_NNS and_CC in_IN the_DT most_RBS rudimentary_JJ way_NN which_WDT makes_VBZ it_PRP ideal_JJ
        for_IN monitoring_VBG large_JJ scale_NN control_NN programmes_NNS in_IN areas_NNS
        where_WRB malaria_NN is_VBZ a_DT serious_JJ problem_NN ._. This_DT diagnostic_JJ test_NN
        also_RB gives_VBZ the_DT general_JJ practitioner_NN a_DT means_NN of_IN immediate_JJ
        diagnosis_NN ,_, which_WDT would_MD overcome_VB the_DT usual_JJ delay_NN associated_VBN
        with_IN dependence_NN on_IN medical_JJ laboratories_NNS ._. Thus_RB rapid_JJ test_NN
        could_MD be_VB a_DT better_RBR diagnostic_JJ method_NN in_IN 
        P_NN ._. falciparum_NN malaria_NN than_IN spleen_NN and_CC
        microscopy_NN ._.
        The_DT fact_NN that_IN a_DT small_JJ proportion_NN of_IN children_NNS (_( 6_CD %_NN )_)
        without_IN 
        P_NN ._. falciparum_NN parasites_NNS in_IN thick_JJ
        smears_NNS were_VBD demonstrated_VBN to_TO have_VB detectable_JJ HRP-_NNP 2_CD antigen_NN
        does_VBZ not_RB reduce_VB the_DT value_NN of_IN the_DT rapid_JJ test_NN ._. Positive_JJ
        results_NNS on_IN the_DT rapid_JJ test_NN ,_, which_WDT can_MD not_RB be_VB verified_VBN
        microscopically_RB have_VBP been_VBN suggested_VBN to_TO be_VB due_JJ to_TO
        circulating_VBG 
        P_NN ._. falciparum_NN HRP-_NNP 2_CD antigen_NN following_VBG
        treatment_NN [_NN 20_CD ]_NN or_CC from_IN sequestered_VBN parasites_NNS [_NN 21_CD ]_NN ._.
        In_IN 4_CD %_NN cases_VBZ the_DT rapid_JJ test_NN gave_VBD false_JJ negative_JJ results_NNS
        compared_VBN to_TO the_DT thick_JJ smear_NN ._. Such_JJ cases_NNS may_MD not_RB have_VB
        sufficient_JJ antigen_NN in_IN the_DT blood_NN for_IN detection_NN by_IN rapid_JJ
        test_NN ._. We_PRP have_VBP estimated_VBN in_IN our_PRP$ earlier_JJR study_NN that_IN the_DT
        threshold_NN parasitaemia_NN for_IN detection_NN by_IN Determine_NNP test_NN to_TO
        be_VB about_IN 500_CD parasites_NNS μl_NN [_NN 10_CD ]_NN ._. However_RB ,_, in_IN this_DT study_NN
        rapid_JJ test_NN failed_VBD to_TO detect_VB 3_CD 
        P_NN ._. falciparum_NN subjects_NNS with_IN ≤_NN 1000_CD μl_NN
        of_IN parasites_NNS ._. Unexplained_NNP false_JJ negative_JJ results_NNS on_IN the_DT
        rapid_JJ test_NN have_VBP been_VBN reported_VBN in_IN many_JJ studies_NNS [_NN 22_CD 23_CD ]_NN and_CC
        rarely_RB even_RB with_IN very_RB high_JJ parasitaemia_NN [_NN 24_CD 25_CD ]_NN ._.
        Further_RB ,_, during_IN this_DT study_NN though_IN we_PRP did_VBD not_RB find_VB the_DT
        patients_NNS with_IN rheumatoid_NN factor_NN ,_, this_DT may_MD need_VB to_TO be_VB
        investigated_VBN further_RB in_IN other_JJ malaria_NN endemic_JJ areas_NNS as_IN a_DT
        relatively_RB high_JJ false_JJ positive_JJ rate_NN with_IN Determine_NNP rapid_JJ
        test_NN was_VBD observed_VBN in_IN patients_NNS with_IN rheumatoid_NN factor_NN in_IN
        earlier_JJR study_NN [_NN 9_CD ]_NN ._.
        Interestingly_RB ,_, in_IN central_JJ India_NNP the_DT largest_JJS state_NN in_IN the_DT
        country_NN ,_, also_RB contributing_VBG highest_JJS number_NN of_IN malaria_NN cases_NNS
        (_( 23_CD %_NN )_) in_IN the_DT country_NN [_NN 26_CD ]_NN ,_, the_DT usual_JJ practice_NN under_IN NAMP_NNP
        is_VBZ to_TO provide_VB radical_JJ treatment_NN (_( Chloroquine_NNP and_CC
        Primaquine_NNP )_) to_TO all_DT fever_NN cases_NNS during_IN monsoon_NN and_CC post_NN
        monsoon_NN season_NN in_IN tribal_NN villages_NNS due_JJ to_TO inaccessibility_NN ._.
        However_RB ,_, as_IN a_DT results_NNS of_IN the_DT emergence_NN of_IN drug_NN resistant_JJ
        malaria_NN ,_, when_WRB Chloroquine_NNP (_( CQ_NNP )_) resistant_JJ 
        P_NN ._. falciparum_NN infections_NNS are_VBP treated_VBN
        with_IN CQ_NNP as_IN CQ_NNP is_VBZ still_RB the_DT first_JJ line_NN of_IN treatment_NN in_IN
        India_NNP ,_, these_DT infections_NNS may_MD be_VB partially_RB controlled_VBN with_IN
        the_DT persistence_NN of_IN low_JJ grade_NN parasitaemia_NN in_IN the_DT peripheral_JJ
        blood_NN [_NN 27_CD ]_NN ._. Such_JJ patients_NNS experience_VBP no_DT symptoms_NNS or_CC
        barely_RB symptomatic_JJ infections_NNS [_NN 28_CD 29_CD ]_NN ._. We_PRP contend_VBP that_IN
        the_DT asymptomatic_JJ infections_NNS which_WDT were_VBD recorded_VBN in_IN this_DT
        study_NN were_VBD mainly_RB infections_NNS of_IN this_DT type_NN ._. These_DT
        asymptomatic_JJ carriers_NNS in_IN remote_JJ villages_NNS are_VBP putting_VBG a_DT
        strain_NN on_IN malaria_NN control_NN activities_NNS ._. Since_IN the_DT number_NN of_IN
        febrile_NN patients_NNS presenting_VBG at_IN most_JJS peripheral_JJ health_NN
        facilities_NNS in_IN central_JJ India_NNP far_RB too_RB high_JJ to_TO test_VB each_DT
        patient_NN for_IN the_DT presence_NN of_IN Plasmodium_NNP species_NNS ,_, hence_RB
        malaria_NN control_NN programme_NN policy_NN is_VBZ to_TO provide_VB fever_NN
        radical_JJ treatment_NN ._. Thus_RB collection_NN and_CC examination_NN of_IN blood_NN
        smears_NNS from_IN asymptomatic_JJ patients_NNS is_VBZ not_RB possible_JJ ._. This_DT
        opens_VBZ new_JJ possibilities_NNS for_IN rapid_JJ screening_NN of_IN communities_NNS
        at_IN risk_NN particularly_RB pregnant_JJ women_NNS and_CC children_NNS [_NN 30_CD 31_CD ]_NN
        in_IN whom_WP correct_JJ diagnosis_NN and_CC treatment_NN is_VBZ especially_RB
        important_JJ [_NN 32_CD ]_NN ._.
        However_RB ,_, a_DT diagnostic_JJ test_NN which_WDT is_VBZ to_TO be_VB used_VBN in_IN
        peripheral_JJ areas_NNS of_IN developing_VBG country_NN has_VBZ to_TO be_VB simple_JJ and_CC
        fast_RB to_TO perform_VB by_IN unskilled_JJ staff_NN ._. While_IN comparing_VBG with_IN
        other_JJ HRP-_NNP 2_CD ,_, Determine_NNP test_NN has_VBZ some_DT advanced_VBN features_NNS ._. The_DT
        ParaSight_NNP F_NNP test_NN requires_VBZ six_CD steps_NNS and_CC 50_CD μl_NN of_IN blood_NN ,_,
        followed_VBN by_IN ICT_NNP which_WDT required_VBD 5_CD steps_NNS and_CC 10_CD μl_NN of_IN blood_NN
        while_IN Determine_NNP assay_NN require_VB 2_CD steps_NNS and_CC 2_CD μl_NN of_IN blood_NN ._.
        Though_IN final_JJ reading_NN time_NN is_VBZ designed_VBN as_IN 30_CD min_NN ,_, which_WDT may_MD
        be_VB a_DT disadvantage_NN particularly_RB during_IN malaria_NN outbreak_NN ,_,
        generally_RB a_DT clear_JJ red_JJ line_NN in_IN patient_NN bar_NN is_VBZ seen_VBN within_IN 10_CD
        minutes_NNS in_IN mild_JJ to_TO moderately_RB parasitaemic_JJ cases_NNS ._. In_IN our_PRP$
        study_NN the_DT reliability_NN of_IN field_NN worker_NN in_IN reading_VBG test_NN
        results_NNS was_VBD excellent_JJ after_IN only_RB brief_JJ on-site_JJ training_NN ._.
        Finally_RB ,_, the_DT application_NN of_IN the_DT rapid_JJ test_NN in_IN the_DT programme_NN
        will_MD be_VB determined_VBN by_IN cost_NN effective_JJ analysis_NN ._. The_DT
        population_NN and_CC countries_NNS at_IN highest_JJS risk_NN from_IN malaria_NN are_VBP
        mainly_RB poorest_JJS and_CC the_DT most_RBS disadvantaged_JJ [_NN 1_CD ]_NN ._. The_DT price_NN
        of_IN the_DT test_NN varies_VBZ with_IN quantity_NN and_CC source_NN of_IN purchase_NN [_NN
        32_CD ]_NN ._. For_IN example_NN the_DT ParaSight_NNP F_NNP test_NN sells_VBZ for_IN US_NNP $_$ 1_CD ._. 20_CD
        /_NN test_NN in_IN Uganda_NNP [_NN 32_CD ]_NN ,_, US_NNP $_$ 2_CD ._. 25_CD in_IN South_JJ Africa_NNP [_NN 33_CD ]_NN
        and_CC US_NNP $_$ 10_CD -_: 13_CD in_IN Europe_NNP ._. The_DT costs_NNS of_IN the_DT ICT_NNP pf_NN tests_VBZ
        ranges_NNS from_IN US_NNP $_$ 1_CD ._. 80_CD /_NN test_NN in_IN developing_VBG countries_NNS [_NN 32_CD ]_NN
        to_TO US_NNP $_$ 27_CD for_IN two_CD test_NN in_IN developed_VBN world_NN ._. These_DT prices_NNS
        appear_VBP prohibitive_JJ at_IN first_JJ sight_NN in_IN a_DT country_NN ,_, which_WDT only_RB
        spends_VBZ a_DT few_JJ dollars_NNS /_NN person_NN /_NN year_NN for_IN health_NN care_NN ._. However_RB
        the_DT picture_NN may_MD look_VB different_JJ when_WRB the_DT total_JJ costs_NNS to_TO
        disease_NN management_NN are_VBP considered_VBN for_IN the_DT community_NN and_CC the_DT
        programme_NN ._. The_DT cost_NN effectiveness_NN advantage_NN of_IN rapid_JJ test_NN
        in_IN the_DT long_JJ term_NN is_VBZ the_DT reduction_NN of_IN mistreatment_NN in_IN terms_NNS
        of_IN drugs_NNS ,_, costs_NNS ,_, toxicity_NN and_CC development_NN of_IN resistance_NN [_NN
        34_CD ]_NN ._. An_DT important_JJ advantage_NN of_IN the_DT availability_NN of_IN the_DT
        rapid_JJ test_NN that_IN it_PRP does_VBZ not_RB depend_VB on_IN just_RB one_CD person_NN but_CC
        can_MD be_VB performed_VBN by_IN all_DT staff_NN members_NNS of_IN the_DT health_NN
        clinic_NN ._.
      
      
        Conclusions_NNP
        In_IN a_DT situation_NN like_IN ours_PRP where_WRB laboratory_NN facilities_NNS are_VBP
        poor_JJ or_CC non-existent_JJ ,_, rapid_JJ test_NN is_VBZ the_DT best_JJS option_NN to_TO
        support_VB malaria_NN diagnosis_NN for_IN case_NN management_NN in_IN malaria_NN
        control_NN programme_NN ._. However_RB ,_, persistent_JJ positive_JJ reactions_NNS
        upto_NN 2_CD weeks_NNS following_VBG treatment_NN [_NN 21_CD ]_NN would_MD not_RB justify_VB
        the_DT introduction_NN of_IN rapid_JJ test_NN as_IN a_DT screening_NN test_NN by_IN
        village_NN health_NN workers_NNS in_IN the_DT region_NN ._. Since_IN the_DT sensitivity_NN
        of_IN the_DT rapid_JJ tests_NNS remains_VBZ high_JJ on_IN treated_VBN patients_NNS
        therefore_RB ,_, it_PRP will_MD be_VB important_JJ to_TO take_VB patients_NNS history_NN
        into_IN consideration_NN during_IN routine_JJ usage_NN of_IN the_DT rapid_JJ tests_NNS ._.
        Furthermore_RB ,_, in_IN the_DT study_NN area_NN ,_, people_NNS are_VBP also_RB subject_JJ to_TO
        other_JJ 
        Plasmodium_NNP infections_NNS i_NNP ._. e_SYM ._. 
        P_NN ._. vivax_NN ,_, which_WDT are_VBP less_RBR common_JJ and_CC
        initially_RB indistinguishable_JJ ._. These_DT non-falciparum_JJ
        plasmodial_NN infections_NNS have_VBP important_JJ therapeutic_JJ and_CC
        prognostic_JJ implications_NNS ._. Thus_RB a_DT second_JJ generation_NN of_IN rapid_JJ
        test_NN 's_POS are_NN required_VBN which_WDT are_VBP intended_VBN to_TO detect_VB and_CC
        distinguish_VB 
        P_NN ._. vivax_NN from_IN 
        P_NN ._. falciparum_NN ._. 
      
    
  
